This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Research Development Foundation, Biogaia Ab, The University of Texas System. Active years: 2006-2023.
Location History:
- Houston, TX (US) (2006 - 2010)
- Pearland, TX (US) (2011 - 2023)
Company Filing History:
5 out of 299 
1 out of 51 
1 out of 5,633 
Years Active: 2006-2023
Title: Yuying Liu: Innovator in Immunology and Therapeutics
Introduction
Yuying Liu is a prominent inventor based in Pearland, Texas, known for her significant contributions to the field of immunology and therapeutic innovations. With a total of six patents to her name, Liu has made strides in developing treatments for immune-related disorders.
Latest Patents
One of Liu's latest patents focuses on the use of inosine for the treatment of T-reg deficiency. This invention provides a method for utilizing inosine to address diseases associated with Treg deficiency or dysfunction, particularly immune dysregulation and the X-linked syndrome known as IPEX. The invention includes the use of a bacterial strain capable of stimulating inosine production, along with methods for selecting such strains. Another notable patent involves therapeutic agents comprising pro-apoptotic proteins. This invention relates to the targeted killing of cells using a chimeric polypeptide that combines a cell-specific targeting moiety with a signal transduction pathway factor, such as granzyme B or Bax.
Career Highlights
Throughout her career, Yuying Liu has worked with various organizations, including the Research Development Foundation and Biogaia AB. Her work has been instrumental in advancing therapeutic strategies for complex immune disorders.
Collaborations
Liu has collaborated with notable professionals in her field, including Michael G. Rosenblum and Stefan Roos. These collaborations have further enriched her research and innovations.
Conclusion
Yuying Liu's contributions to immunology and therapeutic inventions highlight her role as a leading inventor in her field. Her innovative patents and collaborations continue to pave the way for advancements in medical treatments.